zomarist
novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
tandemact
cheplapharm arzneimittel gmbh - pioglitazone, glimepiride - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - tandemact on näidustatud ravi tüüp-2 diabeet diabeediga patsientidel, kellel ilmneb metformiini talumatus või kellele metformiin on vastunäidustatud ja keda juba ravitakse pioglitasooni ja glimepiriidi kombinatsiooniga.
ultravist süste-/infusioonilahus
bayer ag - jopromiid - süste-/infusioonilahus - 623mg 1ml 10ml 10tk; 623mg 1ml 50ml 10tk; 623mg 1ml 500ml 1tk; 623mg 1ml 500ml 8tk; 623mg 1ml 100ml 10tk
ultravist süste-/infusioonilahus
bayer ag - jopromiid - süste-/infusioonilahus - 769mg 1ml 50ml 10tk; 769mg 1ml 100ml 10tk; 769mg 1ml 200ml 10tk; 769mg 1ml 500ml 1tk; 769mg 1ml 500ml 8tk
novofem õhukese polümeerikattega tablett
novo nordisk a/s - noretisteroon+östradiool - õhukese polümeerikattega tablett - 1mg+1mg/0+1mg 36tk / 48tk; 1mg+1mg/0+1mg 12tk / 16tk
eviana õhukese polümeerikattega tablett
novo nordisk a/s - noretisteroon+östradiool - õhukese polümeerikattega tablett - 0,1mg+0,5mg 84tk; 0,1mg+0,5mg 28tk
kliogest õhukese polümeerikattega tablett
novo nordisk a/s - noretisteroon+östradiool - õhukese polümeerikattega tablett - 1mg+2mg 28tk; 1mg+2mg 84tk
ngenla
pfizer europe ma eeig - somatrogon - growth and development - hÜpofÜÜsi ja hÜpotaalamuse hormoonid ja nende analoogid - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).
mycapssa
amryt pharmaceuticals dac - octreotide acetate - akromegaalia - hüpofüüsi ja hüpotaalamuse hormoonid ja analoogid - mycapssa is indicated for maintenance treatment in adult patients with acromegaly who have responded to and tolerated treatment with somatostatin analogues.